Sterility testing of cell lines, media, in-process material and final products must be demonstrated during the manufacture of pharmaceuticals and medical devices.
The sterility test at Creative Bioarray is performed under aseptic conditions in an ISO 14644-1 Class 5 clean room. Experienced microbiologists in Creative Bioarray work directly with the client to ensure recovery method suitability is appropriate for each product configuration.
Creative Bioarray offers the following tests under GLP or GMP:
- Direct Inoculation Sterility for Final Bulk
- Direct Inoculation Sterility for Final Vials
- Direct Inoculation Sterility for Prebanking or Cells at limit
- Direct Inoculation Sterility for Unprocessed Bulk
- Direct Inoculation Sterility for Cells and Virus Banks
- Membrane Filtration Sterility
Three sterility methods are employed at Creative Bioarray.
In this procedure the product if filtered or the device is rinsed, and the rinse liquid passed through a membrane filter. Any microbial cells are retained by the filter. Different filtration units are used for differing products.
The pharmacopeias and 21 CFR 610.12 recommend using two media for both the immersion and membrane filtration methods. In both test methods the test article or membrane is incubated for 14 days in the test media.
Advantages of the membrane filtration method include:
- accommodation of large volume samples (up to 500 ml)
- removal of inhibitory substances that inhibit the growth of microorganisms by rinsing the filter membrane with a suitable agent.
This method is only used when membrane filtration is not possible the sample is inoculated directly into the media or the device is placed directly into the media. This method requires the test article be inoculated directly into test media. Test articles are incubated for 14 days followed by testing for microbial contaminants.
The advantages of the direct inoculation method are:
- sterility testing for materials that cannot be easily filtered
- smaller volumes of test article can be used
Microbial contamination of the test area is assessed throughout the duration of the sterility test, by means of air sampling, settle, contact plates and personnel plates. Creative Bioarray produces and quality controls all of the media used for sterility testing and the media production faciltiy is UKAS accredited.
This method is the method of choice for medical devices because the device is in direct contact with test media throughout the incubation period. Viable microorganisms that may remain in or on a product after sterilization have an ideal environment within which to grow and proliferate. The direct transfer method benefits these damaged microorganisms. The entire product should be immersed in test fluid.
Microbial detection is performed essentially like direct inoculation after a 14 day incubation. Creative Bioarray offers custom protocols to accommodate parts of devices and solids and will work with you to determine the best way to test your articles.
For test articles produced by non-aseptic manufacturing processes, a bioburden (or microbial limits) detection assay should be performed. Furthermore often, it is necessary to evaluate a non-sterile test article for the presence of U.S. FDA criteria for “objectionable organisms.” A microbial limit approach is recommended for the evaluation for objectionable organisms.
If you have any special needs in assessing the sterility of your cells, please contact us at firstname.lastname@example.org or 1-631-626-9181 for this special service. Let us know what you need and we will accommodate you. We look forward to working with you in the future.